KRAS and neoplasm: Tuba-seq analysis of DNA extracted from bulk tumor-bearing lungs allowed us to quantify tumor burden and size across mouse genotypes, and thus determine the tumorigenic potential of BRAF V600E and EGFR L858R relative to KRAS G12C and KRAS G12D.